Skip to main content
. 2024 Nov 12;14:27673. doi: 10.1038/s41598-024-77392-9

Fig. 2.

Fig. 2

Changes in bone microarchitectures of the 2–3 metacarpal over 6 months of abatacept and csDMARDs treatments. Square points and bars represent means and standard deviations, respectively. *†p < 0.05 vs. baseline by the Wilcoxon signed rank test.